Dermatomyositis a rare autoimmune myopathy disease

that targets the muscles and skin. Dermatomyositis causes a characteristic skin rash on the chest, back, or arms that looks like a sunburn. It also causes muscle weakness so severe that it can be hard for some patients to do everyday things such as climbing a flight of stairs, standing… Läs mer

Sandoz receives positive CHMP opinion for proposed biosimilar infliximab


Holzkirchen, Germany, March 23, 2018Sandoz, a Novartis division and the global leader in biosimilars, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for marketing authorization of infliximab, a proposed biosimilar to reference medicine infliximab** *.

The CHMP opinion recommends the proposed Sandoz biosimilar infliximab for the treatment of all indications of its reference medicine across gastroenterology, rheumatology and dermatology.